NEPHROS INC (NEPH)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue TTM

0 8M 16M 24M Q3 '21: 9.9M Q4 '21: 10.3M Q1 '22: 9.7M Q2 '22: 10.3M Q3 '22: 10.1M Q4 '22: 10M Q1 '23: 11.5M Q2 '23: 12.2M Q3 '23: 13.5M Q4 '23: 14.2M Q1 '24: 14.1M Q2 '24: 13.8M Q3 '24: 13.5M Q4 '24: 14.2M Q1 '25: 15.5M Q2 '25: 16.7M Q3 '25: 17.9M Q4 '25: 18.8M Q1 '26: 19.1M Q2 '26: 20.7M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit TTM

0 5M 10M 15M Q3 '21: 5.5M Q4 '21: 5.7M Q1 '22: 5.2M Q2 '22: 5.3M Q3 '22: 4.7M Q4 '22: 4.7M Q1 '23: 5.8M Q2 '23: 6.5M Q3 '23: 7.9M Q4 '23: 8.4M Q1 '24: 8.5M Q2 '24: 8.3M Q3 '24: 8.3M Q4 '24: 8.7M Q1 '25: 9.7M Q2 '25: 10.6M Q3 '25: 11.3M Q4 '25: 11.6M Q1 '26: 11.5M Q2 '26: 12.7M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income TTM

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q3 '21: -3.7M Q4 '21: -3.7M Q1 '22: -4.2M Q2 '22: -3.9M Q3 '22: -4.4M Q4 '22: -4.3M Q1 '23: -3.1M Q2 '23: -2.7M Q3 '23: -1.6M Q4 '23: -1.6M Q1 '24: -1.5M Q2 '24: -1.4M Q3 '24: -960K Q4 '24: 6K Q1 '25: 772K Q2 '25: 1.3M Q3 '25: 1.4M Q4 '25: 1.1M Q1 '26: 677K Q2 '26: 1.6M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income TTM

-7.5M -5M -2.5M 0 2.5M 5M 7.5M Q3 '21: -3.6M Q4 '21: -3.7M Q1 '22: -5.2M Q2 '22: -5.2M Q3 '22: -7.2M Q4 '22: -7.2M Q1 '23: -5.5M Q2 '23: -4.8M Q3 '23: -1.8M Q4 '23: -1.6M Q1 '24: -1.4M Q2 '24: -1.3M Q3 '24: -929K Q4 '24: 74K Q1 '25: 801K Q2 '25: 1.3M Q3 '25: 1.5M Q4 '25: 1.2M Q1 '26: 776K Q2 '26: 1.7M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue TTM

0 3M 6M 9M Q3 '21: 4.4M Q4 '21: 4.6M Q1 '22: 4.6M Q2 '22: 5M Q3 '22: 5.5M Q4 '22: 5.3M Q1 '23: 5.7M Q2 '23: 5.7M Q3 '23: 5.6M Q4 '23: 5.8M Q1 '24: 5.6M Q2 '24: 5.5M Q3 '24: 5.3M Q4 '24: 5.4M Q1 '25: 5.8M Q2 '25: 6.1M Q3 '25: 6.6M Q4 '25: 7.2M Q1 '26: 7.7M Q2 '26: 8M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow TTM

-7.5M -5M -2.5M 0 2.5M 5M 7.5M Q3 '20: -5M Q4 '20: -6.9M Q1 '21: -5.1M Q2 '21: -3.5M Q3 '21: -2.6M Q4 '21: -1.4M Q1 '22: -3.2M Q2 '22: -4.1M Q3 '22: -3.4M Q4 '22: -3.2M Q1 '23: -1.2M Q2 '23: 137K Q3 '23: 869K Q4 '24: -492K Q1 '25: 502K Q2 '25: 2M Q3 '25: 2.7M Q4 '25: 1.6M Q1 '26: -348K Q2 '26: -661K Q4 '20 Q3 '21 Q2 '22 Q1 '23 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow TTM

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q4 '16: -2.2M Q2 '21: -3.6M Q3 '21: -2.6M Q4 '21: -1.5M Q1 '22: -3.2M Q2 '22: -4.3M Q3 '22: -3.5M Q4 '22: -3.4M Q4 '16 Q2 '21 Q3 '21 Q4 '21 Q1 '22 Q2 '22 Q3 '22 Q4 '22

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 20M 40M 60M Q3 '15: 32.6M Q1 '16: 48.2M Q2 '16: 48.5M Q1 '21: 9.9M Q2 '21: 9.9M Q3 '21: 10M Q1 '22: 10.2M Q2 '22: 10.3M Q3 '22: 10.3M Q1 '23: 10.3M Q2 '23: 10.3M Q3 '23: 10.5M Q1 '24: 10.5M Q2 '24: 10.5M Q3 '24: 10.6M Q1 '25: 10.6M Q2 '25: 10.8M Q3 '25: 11M Q1 '26: 11M Q2 '26: 11.1M Q1 '16 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.90 -0.60 -0.30 0.00 0.30 0.60 0.90 Q3 '21: -0.38 Q4 '21: -0.41 Q1 '22: -0.55 Q2 '22: -0.55 Q3 '22: -0.74 Q4 '22: -0.73 Q1 '23: -0.56 Q2 '23: -0.48 Q3 '23: -0.19 Q4 '23: -0.15 Q1 '24: -0.14 Q2 '24: -0.13 Q3 '24: -0.09 Q4 '24: 0.01 Q1 '25: 0.08 Q2 '25: 0.13 Q3 '25: 0.14 Q4 '25: 0.11 Q1 '26: 0.07 Q2 '26: 0.16 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.